185 related articles for article (PubMed ID: 1353703)
1. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines.
Nieuwint AW; Baas F; Wiegant J; Joenje H
Cancer Res; 1992 Aug; 52(16):4361-71. PubMed ID: 1353703
[TBL] [Abstract][Full Text] [Related]
2. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms.
Slovak ML; Coccia M; Meltzer PS; Trent JM
Anticancer Res; 1991; 11(1):423-8. PubMed ID: 1673331
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines.
Zaman GJ; Versantvoort CH; Smit JJ; Eijdems EW; de Haas M; Smith AJ; Broxterman HJ; Mulder NH; de Vries EG; Baas F
Cancer Res; 1993 Apr; 53(8):1747-50. PubMed ID: 8467491
[TBL] [Abstract][Full Text] [Related]
5. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines.
Knutsen T; Rao VK; Ried T; Mickley L; Schneider E; Miyake K; Ghadimi BM; Padilla-Nash H; Pack S; Greenberger L; Cowan K; Dean M; Fojo T; Bates S
Genes Chromosomes Cancer; 2000 Jan; 27(1):110-6. PubMed ID: 10564593
[TBL] [Abstract][Full Text] [Related]
6. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
Versantvoort CH; Broxterman HJ; Pinedo HM; de Vries EG; Feller N; Kuiper CM; Lankelma J
Cancer Res; 1992 Jan; 52(1):17-23. PubMed ID: 1309222
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
Hill AB; Beck WT; Trent JM
Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
[TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
[TBL] [Abstract][Full Text] [Related]
11. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.
Chaudhary PM; Roninson IB
Oncol Res; 1992; 4(7):281-90. PubMed ID: 1360276
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
13. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
Long BH; Wang L; Lorico A; Wang RC; Brattain MG; Casazza AM
Cancer Res; 1991 Oct; 51(19):5275-83. PubMed ID: 1717144
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic characterization of doxorubicin-resistant neuroblastoma cell lines: evidence that acquired multidrug resistance results from a unique large amplification of the 7q21 region.
Flahaut M; Mühlethaler-Mottet A; Martinet D; Fattet S; Bourloud KB; Auderset K; Meier R; Schmutz NB; Delattre O; Joseph JM; Gross N
Genes Chromosomes Cancer; 2006 May; 45(5):495-508. PubMed ID: 16450357
[TBL] [Abstract][Full Text] [Related]
16. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells.
Nakagawa M; Schneider E; Dixon KH; Horton J; Kelley K; Morrow C; Cowan KH
Cancer Res; 1992 Nov; 52(22):6175-81. PubMed ID: 1358431
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.
Slovak ML; Hoeltge GA; Dalton WS; Trent JM
Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069
[TBL] [Abstract][Full Text] [Related]
18. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II.
Cole SP; Chanda ER; Dicke FP; Gerlach JH; Mirski SE
Cancer Res; 1991 Jul; 51(13):3345-52. PubMed ID: 1675932
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of multidrug-resistant human osteosarcoma cell lines.
Serra M; Scotlandi K; Manara MC; Maurici D; Lollini PL; De Giovanni C; Toffoli G; Baldini N
Anticancer Res; 1993; 13(2):323-9. PubMed ID: 8100126
[TBL] [Abstract][Full Text] [Related]
20. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines.
Slovak ML; Ho JP; Bhardwaj G; Kurz EU; Deeley RG; Cole SP
Cancer Res; 1993 Jul; 53(14):3221-5. PubMed ID: 8391919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
